Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

NILUFER A GULEYUPOGLU

Allopathic & Osteopathic Physicians Pain Medicine Interventional Pain Medicine

NPI
1013998996
CMS profile
1251
Location
NEW YORK, NY

General Payments · PY2018–2024

$3,400.38

  • Reported across 154 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$690.98

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $690.98 35

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $433.46 9
PY2019 $237.89 14
PY2020 $428.79 23
PY2021 $348.12 18
PY2022 $417.00 20
PY2023 $844.14 35
PY2024 $690.98 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Azurity Pharmaceuticals, Inc. $15.89 03/27/2024 Food and Beverage Undisputed 01/23/2026 1134006537 CMS
Boston Scientific Corporation $15.21 02/28/2024 Food and Beverage Undisputed 01/23/2026 1092269078 CMS
Collegium Pharmaceutical, Inc. $18.81 01/26/2024 Food and Beverage Undisputed 01/23/2026 1135211283 CMS
Collegium Pharmaceutical, Inc. $20.68 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135245862 CMS
Collegium Pharmaceutical, Inc. $20.68 06/20/2024 Food and Beverage Undisputed 01/23/2026 1135268053 CMS
Collegium Pharmaceutical, Inc. $22.34 08/20/2024 Food and Beverage Undisputed 01/23/2026 1135290722 CMS
Collegium Pharmaceutical, Inc. $21.97 10/24/2024 Food and Beverage Undisputed 01/23/2026 1135317070 CMS
Fidia Pharma USA Inc. $19.74 07/24/2024 Food and Beverage Undisputed 01/23/2026 1141157441 CMS
IBSA Pharma Inc. $20.91 02/02/2024 Food and Beverage Undisputed 01/23/2026 1142979481 CMS
IBSA Pharma Inc. $18.61 02/22/2024 Food and Beverage Undisputed 01/23/2026 1142979483 CMS
SCILEX PHARMACEUTICALS INC. $16.99 01/31/2024 Food and Beverage Undisputed 01/23/2026 1136220937 CMS
SCILEX PHARMACEUTICALS INC. $7.33 01/31/2024 Food and Beverage Undisputed 01/23/2026 1136220941 CMS
SCILEX PHARMACEUTICALS INC. $1.01 02/08/2024 Food and Beverage Undisputed 01/23/2026 1136223172 CMS
SCILEX PHARMACEUTICALS INC. $23.31 02/09/2024 Food and Beverage Undisputed 01/23/2026 1136223654 CMS
SCILEX PHARMACEUTICALS INC. $24.68 03/01/2024 Food and Beverage Undisputed 01/23/2026 1136228526 CMS
SCILEX PHARMACEUTICALS INC. $23.88 03/08/2024 Food and Beverage Undisputed 01/23/2026 1136230075 CMS
SCILEX PHARMACEUTICALS INC. $20.52 03/15/2024 Food and Beverage Undisputed 01/23/2026 1136231946 CMS
SCILEX PHARMACEUTICALS INC. $22.76 04/19/2024 Food and Beverage Undisputed 01/23/2026 1136238187 CMS
SCILEX PHARMACEUTICALS INC. $28.19 05/02/2024 Food and Beverage Undisputed 01/23/2026 1136241268 CMS
SCILEX PHARMACEUTICALS INC. $23.62 05/16/2024 Food and Beverage Undisputed 01/23/2026 1136244735 CMS
SCILEX PHARMACEUTICALS INC. $17.82 05/24/2024 Food and Beverage Undisputed 01/23/2026 1136246892 CMS
SCILEX PHARMACEUTICALS INC. $23.48 06/19/2024 Food and Beverage Undisputed 01/23/2026 1136251911 CMS
SCILEX PHARMACEUTICALS INC. $22.46 07/02/2024 Food and Beverage Undisputed 01/23/2026 1136254197 CMS
SCILEX PHARMACEUTICALS INC. $25.00 07/24/2024 Food and Beverage Undisputed 01/23/2026 1136258689 CMS
SCILEX PHARMACEUTICALS INC. $23.55 08/16/2024 Food and Beverage Undisputed 01/23/2026 1136264677 CMS
SCILEX PHARMACEUTICALS INC. $24.73 08/29/2024 Food and Beverage Undisputed 01/23/2026 1136267788 CMS
SCILEX PHARMACEUTICALS INC. $24.25 09/06/2024 Food and Beverage Undisputed 01/23/2026 1136269381 CMS
SCILEX PHARMACEUTICALS INC. $3.87 09/13/2024 Food and Beverage Undisputed 01/23/2026 1136271297 CMS
SCILEX PHARMACEUTICALS INC. $19.93 09/13/2024 Food and Beverage Undisputed 01/23/2026 1136271301 CMS
SCILEX PHARMACEUTICALS INC. $23.23 10/01/2024 Food and Beverage Undisputed 01/23/2026 1136273889 CMS
SCILEX PHARMACEUTICALS INC. $24.30 10/09/2024 Food and Beverage Undisputed 01/23/2026 1136276170 CMS
SCILEX PHARMACEUTICALS INC. $9.98 11/22/2024 Food and Beverage Undisputed 01/23/2026 1136286520 CMS
SCILEX PHARMACEUTICALS INC. $9.87 11/23/2024 Food and Beverage Undisputed 01/23/2026 1136286643 CMS
SCILEX PHARMACEUTICALS INC. $24.93 12/16/2024 Food and Beverage Undisputed 01/23/2026 1136290756 CMS
VERTEX PHARMACEUTICALS INCORPORATED $26.45 09/24/2024 Food and Beverage Undisputed 01/23/2026 1105923657 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.